The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial

T.C. van Tilborg, M.J.C. Eijkemans, J.S.E. Laven, C.A. Koks, J.P. de Bruin, G.J. Scheffer, R.J. van Golde, K. Fleischer, A. Hoek, A.W. Nap, W.K. Kuchenbecker, P.A. Manger, E.A. Brinkhuis, A.M. van Heusden, A.V. Sluijmer, A. Verhoeff, M.H. van Hooff, J. Friederich, J.M. Smeenk, J. KweeH.R. Verhoeve, C.B. Lambalk, F.M. Helmerhorst, F. van der Veen, B.W.J. Mol, H.L. Torrance, F.J. Broekmans

Research output: Contribution to journalArticleAcademicpeer-review

60 Downloads (Pure)
Original languageUndefined/Unknown
Article number29
Pages (from-to)29
JournalBMC Women's Health
Volume12
DOIs
Publication statusPublished - 2012

Cite this

van Tilborg, T. C., Eijkemans, M. J. C., Laven, J. S. E., Koks, C. A., de Bruin, J. P., Scheffer, G. J., ... Broekmans, F. J. (2012). The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial. BMC Women's Health, 12, 29. [29]. https://doi.org/10.1186/1472-6874-12-29